Etomidate clinical trials
Etomidate is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Early Phase 1. The sponsor with the most trials is Second Hospital of Shanxi Medical University (1). The most-studied condition is Induction Anesthesia. The EU clinical trials register (CTIS) separately lists 1 authorised or ongoing trial.
Where Etomidate is approved
All regulators →Of the three regulators tracked here, the first to approve Etomidate was the US, on 7 Sep 1982. It is approved in 2 of the 3 regulators tracked here.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Etomidate
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Etomidate works
All drug targets →- GABA-A receptor; anion channel positive modulator Positive modulatorTarget: GABA-A receptor; anion channelChEMBL only
- Hypertensive disorderPhase 3
- Ischemic strokePhase 3
- SedationPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL681, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 5463, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Etomidate
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Etomidate
- ATC code
- N01AX07
- ChEMBL
- CHEMBL681
- DrugBank
- DB00292
- PubChem CID
- 667484
- CAS number
- 33125-97-2
- FDA UNII
- Z22628B598
- Wikidata
- Q418445
- Wikipedia
- Etomidate
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Etomidate
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers
NCT07474545 · ClinicalTrials.gov ↗ · Healthy Volunteers
|
Phase 1 | Recruiting | Hunan Kelun Pharmaceutical Co., Ltd | China |
|
Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia
NCT07012902 · ClinicalTrials.gov ↗ · Induction Anesthesia, Drug Interactions
|
Early Phase 1 | Not yet open | Second Hospital of Shanxi Medical University | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Etomidate in the EU trials register (CTIS)
1 trialAuthorised or ongoing trials in the EU Clinical Trials Information System that list a product containing Etomidate. Many trials are registered in both CTIS and ClinicalTrials.gov, so these are shown separately rather than added to the count above. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
|
Effects of General Anaesthetic Agents on the Efficacy of Electroconvulsive Therapy and EEG Changes in Patients with Depression
2025-524829-40-00 · Mental Disorders
|
Phase 4 | Authorised | Varsinais-Suomen hyvinvointialue | Finland |
Etomidate across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- Etomidate InjectionUS (FDA) · Current · updated 3 Nov 2026
Conditions studied with Etomidate
3 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Second Hospital of Shanxi Medical University | 1 |
| Hunan Kelun Pharmaceutical Co., Ltd | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
| EU register (CTIS) | 1 | — |
A trial with sites in more than one country appears in each of those registers. CTIS does not publish a recruiting flag; its trials may also appear in the registers above.
Related compounds
Questions about Etomidate trials
How many clinical trials are testing Etomidate?
2 current trials in our China register name Etomidate as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Etomidate trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Etomidate clinical trials?
Second Hospital of Shanxi Medical University (1) and Hunan Kelun Pharmaceutical Co., Ltd (1). The number in brackets is how many trials each organisation leads.
Is there a Etomidate shortage?
The registers we track list 1 entry for Etomidate: US FDA: current. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Etomidate works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Etomidate works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Etomidate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.